Sign up
Log in
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Sage Therapeutics (NASDAQ:SAGE) shares moved upwards by 35.7% to $9.1 during Monday's regular session. The market value of their outstanding shares is at $569.5 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 30.04% to $0.03. The market value of their outstanding shares is at $10.7 million.
  • Immuneering (NASDAQ:IMRX) stock moved upwards by 18.94% to $2.26. The market value of their outstanding shares is at $81.3 million.
  • NuCana (NASDAQ:NCNA) stock increased by 18.01% to $0.14.
  • Know Labs (AMEX:KNW) stock increased by 17.68% to $3.86. The market value of their outstanding shares is at $28.7 million.
  • Geovax Labs (NASDAQ:GOVX) shares moved upwards by 17.47% to $1.21. The company's market cap stands at $18.3 million.

Losers

  • Sarepta Therapeutics (NASDAQ:SRPT) shares decreased by 44.8% to $19.96 during Monday's regular session. The market value of their outstanding shares is at $1.9 billion.
  • Helius Medical Tech (NASDAQ:HSDT) stock decreased by 27.34% to $0.37.
  • NextCure (NASDAQ:NXTC) stock fell 26.72% to $0.5. The company's market cap stands at $13.9 million.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares decreased by 19.98% to $0.33. The market value of their outstanding shares is at $7.8 million.
  • Imunon (NASDAQ:IMNN) shares declined by 18.89% to $1.16. The market value of their outstanding shares is at $20.3 million.
  • OKYO Pharma (NASDAQ:OKYO) stock fell 15.95% to $2.53. The market value of their outstanding shares is at $85.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.